Business Description
Acticor Biotech SA
ISIN : FR0014005OJ5
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.13 | |||||
Equity-to-Asset | 0.03 | |||||
Debt-to-Equity | 19.15 | |||||
Debt-to-EBITDA | -0.44 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -47.7 | |||||
3-Year EPS without NRI Growth Rate | -46 | |||||
3-Year FCF Growth Rate | -41.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.34 | |||||
9-Day RSI | 56.89 | |||||
14-Day RSI | 53.95 | |||||
6-1 Month Momentum % | -22.56 | |||||
12-1 Month Momentum % | -47.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.52 | |||||
Quick Ratio | 1.52 | |||||
Cash Ratio | 0.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -19.32 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -2298.56 | |||||
ROA % | -145.09 | |||||
ROIC % | -516.11 | |||||
ROC (Joel Greenblatt) % | -7612.38 | |||||
ROCE % | -258.46 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 127.33 | |||||
EV-to-EBIT | -3.64 | |||||
EV-to-EBITDA | -3.68 | |||||
EV-to-FCF | -4.68 | |||||
Earnings Yield (Greenblatt) % | -27.47 | |||||
FCF Yield % | -22.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Acticor Biotech SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.67 | ||
Beta | 0 | ||
Volatility % | 73.52 | ||
14-Day RSI | 53.95 | ||
14-Day ATR (€) | 0.208829 | ||
20-Day SMA (€) | 3.561 | ||
12-1 Month Momentum % | -47.2 | ||
52-Week Range (€) | 2.72 - 6.22 | ||
Shares Outstanding (Mil) | 15.69 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Acticor Biotech SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Acticor Biotech SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Acticor Biotech SA Frequently Asked Questions
What is Acticor Biotech SA(XPAR:ALACT)'s stock price today?
When is next earnings date of Acticor Biotech SA(XPAR:ALACT)?
Does Acticor Biotech SA(XPAR:ALACT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |